Advertisement

Topics

Seqirus to invest £40 million into UK vaccine manufacturing site

14:42 EST 8 Nov 2017 | thePharmaLetter

Seqirus, the company created in 2015 when Australian biotech CSL Limited acquired Swiss pharma giant…

Original Article: Seqirus to invest £40 million into UK vaccine manufacturing site

NEXT ARTICLE

More From BioPortfolio on "Seqirus to invest £40 million into UK vaccine manufacturing site"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...